Biomarkers of Depressive Disorder and Dietary Intervention Strategies
Keywords:
Depressive disorder, biomarkers, nutritional psychiatry, Mediterranean diet, inflammation, gut-brain axisAbstract
Depressive disorder (DD) is a multifactorial mental illness involving dysregulation across neuroendocrine, immune, metabolic, and microbial systems. Despite substantial research progress, diagnostic and therapeutic approaches remain largely symptom-based, lacking biological precision. This study addresses this gap by systematically reviewing key biomarkers, such as cortisol, IL-6, CRP, BDNF, and the kynurenine/tryptophan ratio, and examining their modulation through dietary interventions. Using an integrative literature analysis spanning psychiatry, molecular biology, and nutritional science, the paper explores how the Mediterranean diet, anti-inflammatory diet, and probiotics/prebiotics regulate inflammatory cytokines, neurotrophic factors, and gut microbiota activity. Results indicate that these nutritional models can attenuate systemic inflammation, enhance neurotrophic signaling, normalize HPA axis function, and restore microbial balance, thereby improving depressive symptoms. The findings underscore the potential of a biomarker-guided, diet-based framework for precision management of depression. Academically, the study contributes to the conceptual integration of biomarker and nutritional psychiatry research; practically, it offers an evidence-based foundation for individualized, non-pharmacological adjunct therapies in mental health care.References
1. B. W. Marx, M. Penninx, M. Solmi, T. A. Furukawa, J. Firth, A. F. Carvalho, and M. Berk, "Major depressive disorder," Nature Reviews Disease Primers, vol. 9, no. 1, p. 44, 2023.
2. S. Yang, L. Y. Zhang, C. H. Yang, X. Y. Li, and Z. Q. Li, "Global, regional, and national epidemiology of depression in working-age individuals, 1990-2019," *Depression and Anxiety*, vol. 2024, no. 1, p. 4747449, 2024.
3. H. Stolfi, R. Abreu, R. Sinella, S. Nembrini, S. Centonze, V. Landra, and A. Chiocchetti, "Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine," Frontiers in Psychiatry, vol. 15, p. 1422939, 2024. doi: 10.3389/fpsyt.2024.1422939
4. U. Accorroni, U. Nencha, and I. Bègue, "The interdisciplinary synergy between neurology and psychiatry: advancing brain health," Clinical and Translational Neuroscience, vol. 9, no. 1, p. 18, 2025. doi: 10.3390/ctn9010018
5. X. Luo, M. Q. Yu, M. Q. Zeng, C. Z. Duan, S. Y. Xu, C. Y. Zhu, and D. J. He, "Breaking the diabetes-depression cycle: exploring shared mechanisms, neuroinflammation, and emerging interventions for metabolic-mood comorbidities," World Journal of Diabetes, vol. 16, no. 7, p. 107406, 2025.
6. S. Machado, A. McNaughton, K. Wingrove, L. D. Stephens, P. Baker, and M. Lawrence, "A scoping review of the causal pathways and biological mechanisms linking nutrition exposures and health outcomes," Current Nutrition Reports, vol. 14, no. 1, p. 3, 2024. doi: 10.1007/s13668-024-00591-3
7. G. Marx, G. Moseley, M. Berk, and F. Jacka, "Nutritional psychiatry: the present state of the evidence," Proceedings of the Nutrition Society, vol. 76, no. 4, pp. 427-436, 2017. doi: 10.1017/s0029665117002026
8. V. Merino del Portillo, V. J. Clemente-Suarez, P. Ruisoto, M. Jimenez, D. J. Ramos-Campo, A. I. Beltran-Velasco, and J. F. Tornero-Aguilera, "Nutritional modulation of the gut-brain axis: A comprehensive review of dietary interventions in depression and anxiety management," Metabolites, vol. 14, no. 10, p. 549, 2024.
9. M. A. Ibrahim, "The role of psychotherapy and pharmacotherapy in managing major depressive disorder," International Journal of Psychological Sciences, vol. 7, no. 1, pp. 18-27, 2025. doi: 10.33545/26648377.2025.v7.i1a.62
10. L. Brown, A. Bleich, and H. M. Van Praag, "The monoamine hypothesis of depression: The case for serotonin," in Role of Serotonin in Psychiatric Disorders, 2023, pp. 91-128.
11. H. Cao, H. Jiang, P. Chen, and C. Dai, "Role of depression-mediated alterations in pro-inflammatory cytokines in carcinogenesis," Frontiers in Immunology, vol. 16, p. 1659153, 2025. doi: 10.3389/fimmu.2025.1659153
12. S. Correia and N. Vale, "Advancements exploring major depressive disorder: insights on oxidative stress, serotonin metabolism, BDNF, HPA axis dysfunction, and pharmacotherapy advances," International Journal of Translational Medicine, vol. 4, no. 1, pp. 176-196, 2024. doi: 10.3390/ijtm4010010
13. W. Zhao, W. Wang, M. Wang, F. Gao, C. Hu, B. Cui, and H. Ren, "Personalized individual-based exercise prescriptions are effective in treating depressive symptoms of college students during the COVID-19: a randomized controlled trial in China," Frontiers in Psychiatry, vol. 13, p. 1015725, 2023. doi: 10.3389/fpsyt.2022.1015725
14. S. S. Hunjan, S. Shah, S. Kosey, and K. R. Aran, "Gut microbiota and the tryptophan-kynurenine pathway in anxiety: new insights and treatment strategies: Gut microbiota and the tryptophan-kynurenine pathway," Journal of Neural Transmission, vol. 132, no. 7, pp. 943-977, 2025.
15. A. Tavakoly, A. Moosburner, D. Anheyer, and H. Cramer, "Effect of different dietary patterns on patients with depressive disorders: a systematic review and meta-analysis of randomized controlled trials," Nutrients, vol. 17, no. 3, p. 563, 2025. doi: 10.3390/nu17030563
